Skip Ribbon Commands
Skip to main content

Life Sciences/ Lab Report

United States | Seattle, WA

Report | Seattle Life Sciences Outlook - 2013-2014


Activity and demand within the life sciences industry seems to have shifted from one driven by Big Pharma companies, to one where mid-tier companies and specialty players are experiencing overnight growth and highly variable needs in response to promising products and treatments.

Although markets with a large presence of Big Pharma headquarter campuses have reported upticks in sublease and sale activity, opportunity exists in retrofitting and parceling large campuses to meet the growing needs of the mid-tier and specialty pharma companies.

To access the report, simply complete the form.

Please fill out the form to access the report.
Trouble downloading? Please click the following link.